FindTrial
Sign In

Pulsed Radiofrequency for Chronic Mastalgia of Fibrocystic Disease of the Breast

for Patients With Fibrocystic Disease of the Breast, Does Pulsed Radiofrequency on Thoracic Paravertebral Nerve Reduce Pain Severity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03888963
Enrollment
10
Registered
2019-03-25
Start date
2019-03-28
Completion date
2019-09-20
Last updated
2019-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The investigators will evaluate the analgesic efficacy of pulsed radiofrequency on the thoracic paravertebral nerves for patients with chronic mastalgia of fibrocystic disease of the breast

Interventions

PROCEDURESHAM

patients will be subjected to the same procedure like PRF group without giving PRF

PROCEDUREPRF

patients will receive pulsed radiofrequency, 4 cycles (each cycle, 2 minutes) on the thoracic paravertebral nerves number 2,3, and 4 under fluroscopic guidance

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients with chronic mastalgia due to fibrocystic disease of the breast * the pain duration maintained for more than 1 year * the pain intensity is more than 5 on VAS pain score

Exclusion criteria

* coagulopathy * infection at the site of the procedure

Design outcomes

Primary

MeasureTime frameDescription
the changes in pain intensity measured by VAS pain scorepatients will be evaluated at 3 months postoperativelyVAS pain score, is a scale for pain measurements scored from 0 to 10 in which 0 = no pain and 10 = the worst imaginable pain

Countries

Egypt

Contacts

Primary Contactdiab hetta, MD
diabhetta25@gmail.com+201091090009

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026